Compare Live Nation Entertainment, Inc. (LYV) vs 22nd Century Group Inc (XXII) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Live Nation Entertainment, Inc. vs 22nd Century Group Inc — how do they compare? Live Nation Entertainment, Inc. trades at $170.33 (market cap $39.92B), while 22nd Century Group Inc trades at $0.81 (market cap $621.67K). The key difference: Live Nation Entertainment, Inc. is far larger — about 64214.1× 22nd Century Group Inc's market cap, and Live Nation Entertainment, Inc. is trading nearer its 52-week high, 22nd Century Group Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Live Nation Entertainment, Inc. for 72 Days and 22nd Century Group Inc for 32 Days on average.
| LYV | XXII | |
|---|---|---|
Market Cap | $39.92B | $621.67K |
Volume | 1,982,609 | 45,625 |
Sector | Media | Consumer Staples |
52-Week High | $188.46 | $483.00 |
52-Week Low | $125.61 | $0.80 |
Typical Hold Time | 72 Days | 32 Days |
Enterprise Value | $42.13B | -$3.69M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
LYV trades at $171.34, up 0.29% on the day, with a bullish technical signal from moving averages and neutral oscillators. The company reported Q2 2026 earnings that beat expectations with EPS of $1.05 versus $0.66 expected, driven by strong attendance and record deferred revenue. Revenue for 2025 reached $25.20 billion, though net income margin narrowed to 1.96%. Analyst consensus is strongly bullish with 40 buy ratings and a $208.18 price target, reflecting optimism around live event demand.
The outlook for LYV remains positive given robust fan demand and strategic expansions, but high valuation multiples, debt levels, and regulatory scrutiny pose risks. Earnings visibility is supported by $6.4 billion in deferred revenue, though margin pressure and legal uncertainties could temper near-term gains. The stock offers growth exposure to the experience economy, yet investors should weigh execution risks against bullish analyst sentiment.
XXII trades at $0.8116, down 8.96% in the last session, with a bearish technical signal from moving averages. The company shows negative profitability metrics including -76.01% net income margin and -284.5% ROE, though valuation ratios appear low with P/S of 0.08 and P/B of 0.03. Recent news highlights regulatory progress in reduced-nicotine tobacco initiatives in France and Europe.
While analyst consensus is 75% buy with a $1,240 price target suggesting significant upside, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock faces execution risk in commercializing its reduced-nicotine platform amid ongoing losses.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Live Nation Entertainment, Inc.
Live Nation is the largest live entertainment firm in the world with over 570 million fans served in 44 countries in 2018 by the company's concert and ticketing platforms. Via either owning, operating, or holding exclusive booking rights, Live Nation controls over 235 venues including the House of Blues, the Hollywood Palladium, and Spark Arena in New Zealand. Live Nation also owns one of the largest ticketing services, Ticketmaster, which sold over 480 million tickets for over 12,000 clients in 2018. The firm's artist management agencies have over 400 clients. This large live entertainment footprint helped Live Nation become one of the largest advertising and sponsorship platforms aimed at music fans. Liberty Media owns 33% of Live Nation, held under its SiriusXM tracking stock.
Read more on LYV →About 22nd Century Group Inc
22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →
